Patents
Literature
10 results about "T cell immunotherapy" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The FDA approved CAR (chimeric antigen receptor) T-cell immunotherapy, a treatment in which a patient's T-cells, the soldiers of the immune system, are genetically reprogrammed to find and kill cancer cells. LLS recognized the early promise of this approach. Over more than two decades, LLS provided $40 million in funding...